Literature DB >> 11793444

Molecular analysis of nonrandom 8q12 deletions in acute lymphoblastic leukemia: identification of two candidate genes.

Valérie Bardet1, Nathalie Couque, Laurence Cattolico, Gilles Hetet, Isabelle Devaux, Simone Duprat, Laetitia Gressin, Etienne Vilmer, Hélène Cavé, Bernard Grandchamp.   

Abstract

Acute lymphoblastic leukemia is the most common malignancy in childhood. High-resolution allelotyping performed in our laboratory showed new chromosomal sites of nonrandom deletions. We have focused our work on 8q12 deletions, which we have found in about 4% of patients (eight of 205 informative cases). These deletions were of small size (less than 1 Mb) in all but one patient, and the deleted region common to all patients was delineated between two microsatellite markers (D8S1113 and D8S1763). This region was sequenced entirely from two overlapping bacterial artificial chromosomes. The common deleted region (120 kb) had a low GC content (37%), was composed more than 50% of LINE sequences, and contained only two candidate genes. The centromeric deletion borders were clustered within an interval of 33 kb between two microsatellite markers. This interval contains the first exon of an HMG-1-related gene (KIAA0808) and a putative gene, DL8q12, predicted to encode a protein with 231 amino acid residues with no homolog in protein databases. Analysis of the available mRNA from lymphoblastic cells of two patients with 8q12 deletions using common polymorphisms in the 3' UTR of KIAA0808 showed monoallelic expression of this gene. Identification of a biallelic polymorphism in the first exon of DL8q12 showed that this gene was deleted in two of four informative cases. Sequencing of the exons of both genes from all patients with 8q12 deletions did not show any mutation, which suggests that neither of these genes behaves as a classic tumor suppressor gene. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11793444     DOI: 10.1002/gcc.10014

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  2 in total

1.  TOX acts an oncological role in mycosis fungoides.

Authors:  Xin Yu; Yixin Luo; Jie Liu; Yuehua Liu; Qiuning Sun
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

Review 2.  TOX as a potential target for immunotherapy in lymphocytic malignancies.

Authors:  Chaofeng Liang; Shuxin Huang; Yujie Zhao; Shaohua Chen; Yangqiu Li
Journal:  Biomark Res       Date:  2021-03-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.